Featured Research

from universities, journals, and other organizations

Risk Factors For Retinopathy In Persons With Type 1 Diabetes

Date:
November 3, 2008
Source:
American Academy of Ophthalmology
Summary:
Many people who have Type 1 or Type 2 diabetes develop retinopathy, a serious disorder that damages the eye's retina, the area of the back of the eye where images are focused and relayed to the brain's visual cortex. Ophthalmologists (Eye M.D.s) monitor their diabetic patients for signs of retinopathy and use lifestyle recommendations, medications, and surgical approaches as appropriate to reduce the risk that diabetic retinopathy (DR) will progress to the proliferative stage (PDR), in which abnormal blood vessel growth leads to visual impairment.

Many people who have Type 1 or Type 2 diabetes develop retinopathy, a serious disorder that damages the eye's retina, the area of the back of the eye where images are focused and relayed to the brain's visual cortex. Ophthalmologists (Eye M.D.s) monitor their diabetic patients for signs of retinopathy and use lifestyle recommendations, medications, and surgical approaches as appropriate to reduce the risk that diabetic retinopathy (DR) will progress to the proliferative stage (PDR), in which abnormal blood vessel growth leads to visual impairment.

In recent years the diagnosis, prevention and treatment of DR and PDR have improved markedly.

The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) is a large, long-term study that confirmed and expanded on results of other significant DR studies such as the Diabetes Control and Complications Trial. Ronald Klein, MD, and colleagues evaluated factors associated with the progression or regression of retinopathy over a 25 year period in people who had been diagnosed with Type 1 diabetes before the age of 30 years. The key finding was that glycemic control---assessed via blood levels of glycosylated hemoglobin A1, a reliable measure of average blood sugar---at the time of the baseline exam and throughout the study was strongly related to whether a patient's DR worsened or improved.

This confirmed findings of a number of earlier large studies. Better glycemic control was associated with significant reduction in DR progression and increased improvement in DR independent of how long the patient had had Type 1 diabetes and the level of DR at the baseline exam. Other risk factors found by the WESDR to be associated with progression to PDR included male gender, higher blood pressure level, presence of protein in urine (a manifestation of diabetic kidney disease) and a greater body mass index as measured at baseline.

WESDR participants were 955 insulin-taking Type 1 diabetics who received baseline exams between 1980 and 1982 and were either evaluated again four years later or died before the four-year follow up. Additional follow up exams were done at 10, 14 and 25 years post-baseline, and 520 of the original participants completed the 25-year follow-up.

Based on WESDR findings, the researchers estimate that over a 25-year period, 185,000 to 466,000 Americans with Type 1 diabetes will develop PDR. Dr. Klein adds the caution that these numbers may be an overestimation, because PDR incidence has declined in people diagnosed with Type 1 diabetes in recent years, possibly due to proactive and improved treatment of glycemia and blood pressure.


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Ophthalmology. "Risk Factors For Retinopathy In Persons With Type 1 Diabetes." ScienceDaily. ScienceDaily, 3 November 2008. <www.sciencedaily.com/releases/2008/11/081103141958.htm>.
American Academy of Ophthalmology. (2008, November 3). Risk Factors For Retinopathy In Persons With Type 1 Diabetes. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2008/11/081103141958.htm
American Academy of Ophthalmology. "Risk Factors For Retinopathy In Persons With Type 1 Diabetes." ScienceDaily. www.sciencedaily.com/releases/2008/11/081103141958.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins